These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14280911)

  • 1. THE MARGULIES INTRAUTERINE CONTRACEPTIVE DEVICE: EXPERIENCE WITH 623 WOMEN.
    WILLSON JR; LEDGER WJ; BOLLINGER CC; ANDROS GJ
    Am J Obstet Gynecol; 1965 May; 92():62-70. PubMed ID: 14280911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrauterine contraception with copper-T 200 device- a retrospective analysis of 334 cases (author's transl)].
    Salzer H; Schneider WH; Eppel W
    Wien Klin Wochenschr; 1981 May; 93(11):354-8. PubMed ID: 7269615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with the Margulies intrauterine contraceptive device.
    Johnson FL; Doerffer FR; Tyson JE
    Can Med Assoc J; 1966 Jul; 95(1):14-20. PubMed ID: 5943692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [RESULTS OF THE SURGICAL TREATMENT OF SO-CALLED "EROSIONS" OF THE CERVIX UTERI (BASED ON THE MATERIAL OF THE ONCOLOGICAL INSTITUTE OF THE ACADEMY OF MEDICAL SCIENCES OF THE USSR DURING THE PAST 15 YEARS, 1946-1960)].
    ROGOVENKO SS
    Vopr Onkol; 1963; 9():77-83. PubMed ID: 14148620
    [No Abstract]   [Full Text] [Related]  

  • 6. [TREATMENT OF GONORRHEA IN WOMEN WITH PENICILLIN COMBINED WITH STREPTOMYCIN].
    ROBACHEVSKII GR
    Akush Ginekol (Mosk); 1963; 39():95-8. PubMed ID: 14148728
    [No Abstract]   [Full Text] [Related]  

  • 7. Pelvic actinomycosis and the intrauterine contraceptive device. A cyto-histomorphologic study.
    Luff RD; Gupta PK; Spence MR; Frost JK
    Am J Clin Pathol; 1978 Jun; 69(6):581-6. PubMed ID: 665579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best practices to minimize risk of infection with intrauterine device insertion.
    Caddy S; Yudin MH; Hakim J; Money DM; ;
    J Obstet Gynaecol Can; 2014 Mar; 36(3):266-274. PubMed ID: 24612897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intrauterine contraceptive device.
    Barwin BN; Tuttle S; Jolly EE
    Can Med Assoc J; 1978 Jan; 118(1):53-8. PubMed ID: 620385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE EFFECT OF THE INTRAUTERINE CONTRACEPTIVE COIL ON THE OVIDUCT.
    SIEGLER AM; HELLMAN LM
    Obstet Gynecol; 1964 Feb; 23():173-5. PubMed ID: 14117320
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonorrhoea and the intrauterine contraceptive device.
    Statham R; Morton RS
    Br Med J; 1968 Dec; 4(5631):623-5. PubMed ID: 4972751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrauterine device and genital infection].
    Barrat J; Faguer C
    Contracept Fertil Sex (Paris); 1976 Mar; 4(2):87-92. PubMed ID: 1261727
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
    Milsom I; Andersson K; Andersch B; Rybo G
    Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrauterine contraceptive device: an often-forgotten and maligned method of contraception.
    Dardano KL; Burkman RT
    Am J Obstet Gynecol; 1999 Jul; 181(1):1-5. PubMed ID: 10411781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study.
    Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Bass DC; Kelsey SF;
    Am J Obstet Gynecol; 2001 Jul; 185(1):121-7. PubMed ID: 11483915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonococcal infections.
    Holder NA
    Pediatr Rev; 2008 Jul; 29(7):228-34. PubMed ID: 18593752
    [No Abstract]   [Full Text] [Related]  

  • 18. Pelvic infection: a comparison of the Dalkon shield and three other intrauterine devices.
    Snowden R; Pearson B
    Br Med J (Clin Res Ed); 1984 May; 288(6430):1570-3. PubMed ID: 6426647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE EFFECT OF AN INTRAUTERINE CONTRACEPTIVE DEVICE ON THE BACTERIAL FLORA OF THE ENDOMETRIAL CAVITY.
    WILLSON JR; BOLLINGER CC; LEDGER WJ
    Am J Obstet Gynecol; 1964 Nov; 90():726-39. PubMed ID: 14233660
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrauterine contraceptive devices.
    Frampton J; Mathews D
    Br Med J; 1967 Jun; 2(5553):683-7. PubMed ID: 6067250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.